UK markets close in 7 hours 33 minutes

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
189.64+0.39 (+0.21%)
At close: 4:04PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
24,539,800
24,539,800
22,319,500
24,555,700
22,871,300
Cost of revenue
5,483,300
5,483,300
4,721,200
6,430,000
6,070,200
Gross profit
19,056,500
19,056,500
17,598,300
18,125,700
16,801,100
Operating expenses
Research development
6,085,700
6,085,700
5,595,000
5,307,100
5,281,800
Selling general and administrative
6,121,200
6,121,200
6,213,800
6,631,800
7,101,800
Total operating expenses
12,206,900
12,206,900
11,808,800
11,938,900
12,383,600
Operating income or loss
6,849,600
6,849,600
5,789,500
6,186,800
4,417,500
Interest expense
359,600
359,600
400,600
272,100
225,000
Total other income/expenses net
706,900
706,900
-203,400
-2,280,300
-2,162,400
Income before tax
7,229,900
7,229,900
5,265,900
3,795,700
2,197,400
Income tax expense
1,036,200
1,036,200
628,000
563,700
2,401,500
Income from continuing operations
6,193,700
6,193,700
4,637,900
3,232,000
-204,100
Net income
6,193,700
6,193,700
8,318,400
3,232,000
-204,100
Net income available to common shareholders
6,193,700
6,193,700
8,318,400
3,232,000
-204,100
Basic EPS
-
-
8.69
3.14
-0.19
Diluted EPS
-
-
8.69
3.13
-0.19
Basic average shares
-
-
957,526
1,027,721
1,052,023
Diluted average shares
-
-
957,526
1,033,667
1,052,023
EBITDA
-
8,913,400
6,899,100
5,676,800
3,989,700